A5003322132- HIV Research and Treatment
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Mobile Health and mHealth Applications
- Evolutionary Psychology and Human Behavior
- Infectious Diseases and Tuberculosis
- Forensic and Genetic Research
- Evolutionary Game Theory and Cooperation
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Global Maternal and Child Health
- HIV, Drug Use, Sexual Risk
- Image Processing and 3D Reconstruction
- Vaccine Coverage and Hesitancy
- Mathematical and Theoretical Epidemiology and Ecology Models
- Forensic Fingerprint Detection Methods
Boston University
2025
Public Health Institute
2024
Center for Global Health
2024
Centers for Disease Control and Prevention
2024
ABSTRACT Introduction South African young adults are at increased risk for HIV acquisition and other non-communicable diseases face significant barriers to accessing healthcare services. The rapid development of artificial intelligence (AI), in particular AI-powered assistants (AIPHA), presents a unique opportunity increase access health information linkage services providers. While successful implementation uptake such tools require understanding user preferences, limited these preferences...
Background: In 2019, South Africa’s Antiretroviral Therapy (ART) Treatment Guidelines replaced efavirenz with dolutegravir in first-line ART. Setting: We assessed the impact of this national guideline change on retention and viral suppression Themba Lethu Clinical Cohort, Johannesburg, Africa. applied a regression discontinuity design prospective cohort study 1654 adults living HIV initiating ART within 12 months (±12 months) change. Methods: compared outcomes individuals presenting just...
Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities people affected by TB are experts in their care pathways, but field continues to fall short meaningfully engaging communities research. This a missed opportunity improve quality, relevance, person-centeredness, positive impact, sustainability research outputs. We acknowledge important progress that has been made date regarding community engagement TB,...
Positive results of introduction project NBIС conducted by NIST in conjunction with ATF. The is designed to ensure the quality ballistic identification laboratories USA.
The Sedia Biosciences Asanté rapid test for recent infection (RTRI) can identify HIV infections and characterize HIV-1 as or long-term via the positive verification (V) line (LT) line, respectively. Tracking with Recency Assays to Control Epidemic (TRACE) program uses RTRI assays. Successful implementation of TRACE requires high-quality performance. goal this study is evaluate additional quality practices established new kit lots prior field use. lot control data from manufacturer reviewed...
We developed the HIV Triplex multiplex bead assay to identify and serotype infection with high sensitivity specificity; distinguish recent from long-term HIV-1 infections. It can facilitate accurate incidence estimation, while reducing number of tests blood collected, which is highly desirable for use in future studies surveys. Using previously treatment-naive longitudinal seroconversion positive panels specimens individuals infected >12 months, we determined assay's mean duration (MDRI)...